Record NNP B-NP O
date NN I-NP O
: : O O
2097-08-28 CD O B-DATE
INTERN/MED NN B-NP O
STUDENT NNP I-NP O
ADMIT NNP I-NP O
NOTE NNP I-NP O
, , O O
Team NNP B-NP O
3 CD I-NP O
Name NN B-NP O
: : O O
Mr. NNP B-NP O
Danny NNP I-NP B-PATIENT
Nielson NNP I-NP I-PATIENT
MR NNP B-NP O
# # I-NP O
: : O O
9156593 CD O B-MEDICALRECORD
Date NNP B-NP O
of IN B-PP O
admission NN B-NP O
: : O O
08/28/2097 CD O B-DATE
Admitting NNP B-NP O
Physician NNP I-NP O
: : O O
Dr. NNP B-NP O
Gene NNP I-NP B-DOCTOR
Quadri NNP I-NP I-DOCTOR
, , O O
MD . O O
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
Ulises NNP I-NP B-DOCTOR
Noel NNP I-NP I-DOCTOR
Source NN B-NP O
of IN B-PP O
Hx NNP B-NP O
: : O O
Patient NNP B-NP O
, , O O
Available JJ B-NP O
note NN I-NP O
Code NNP B-NP O
: : O O
Full . O O
CC NNP B-NP O
: : O O
Want VBP B-VP O
to TO I-VP O
get VB I-VP O
my PRP$ B-NP O
chemo NN I-NP O
ID NNP B-NP O
: : O O
Mr. NNP B-NP O
Nielson NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
77 CD I-NP B-AGE
yoM NNP I-NP O
w/ NN I-NP O
Stage NNP I-NP O
IIIB NNP I-NP O
diffuse VBP B-VP O
large JJ B-NP O
B-cell JJ I-NP O
lymphoma NN I-NP O
s/p NN I-NP O
4 CD B-NP O
cycles NNS I-NP O
of IN B-PP O
CHOP NNP B-NP O
and CC O O
1 CD B-NP O
cycle NN I-NP O
of IN B-PP O
R-ICE NNP B-NP O
who WP B-NP O
presents VBZ B-VP O
now RB B-ADVP O
for IN B-PP O
cycle NN B-NP O
2 CD I-NP O
of IN B-PP O
R-ICE. PRP$ B-NP O
HPI NNP B-NP O
: : O O
Mr. NNP B-NP O
Nielson NNP I-NP B-PATIENT
was VBD B-VP O
in IN B-PP O
his PRP$ B-NP O
usual JJ I-NP O
state NN I-NP O
of IN B-PP O
health NN B-NP O
until IN B-PP O
March NNP B-NP B-DATE
of IN B-PP O
this DT B-NP O
year NN I-NP O
when WRB B-ADVP O
he PRP B-NP O
began VBD B-VP O
noticing VBG I-VP O
increasing VBG I-VP O
swelling VBG I-VP O
in IN B-PP O
his PRP$ B-NP O
left JJ I-NP O
leg NN I-NP O
over IN B-PP O
a DT B-NP O
period NN I-NP O
of IN B-PP O
three CD B-NP O
weeks NNS I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
developed VBD B-VP O
b/l JJ B-NP O
groin NN I-NP O
swelling VBG B-VP O
greater JJR B-NP O
on IN B-PP O
the DT B-NP O
left NN I-NP O
; : O O
the DT B-NP O
swelling VBG I-NP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
groin NN I-NP O
was VBD B-VP O
tender JJ B-ADJP O
. . O O
He PRP B-NP O
presented VBD B-VP O
in IN B-PP O
early JJ B-NP O
April NNP I-NP B-DATE
where WRB B-ADVP O
CT NNP B-NP O
and CC I-NP O
PET NNP I-NP O
scan NN I-NP O
of IN B-PP O
the DT B-NP O
pelvis NN I-NP O
and CC I-NP O
abdomen NN I-NP O
revealed VBD B-VP O
a DT B-NP O
6.0 CD I-NP O
cm NN I-NP O
inguinal JJ I-NP O
node NN I-NP O
, , O O
a DT B-NP O
chain NN I-NP O
of IN B-PP O
nodes NNS B-NP O
in IN B-PP O
the DT B-NP O
retrocrural JJ I-NP O
space NN I-NP O
, , O O
adenopathy NN B-NP O
in IN B-PP O
the DT B-NP O
external JJ I-NP O
iliac NN I-NP O
chain NN I-NP O
( -LRB- I-NP O
largest JJS I-NP O
3.5 CD I-NP O
cm NN I-NP O
) -RRB- I-NP O
, , O O
and CC O O
two CD B-NP O
nodes NNS I-NP O
in IN B-PP O
the DT B-NP O
retroperitoneal JJ I-NP O
space NN I-NP O
in IN B-PP O
between IN B-PP O
the DT B-NP O
IVC NNP I-NP O
and CC O O
aorta DT B-NP O
. . O O
He PRP B-NP O
underwent VBD B-VP O
biopsy NN B-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
groin NN I-NP O
mass NN I-NP O
two CD B-NP O
weeks NNS I-NP O
later RB B-VP O
revealing VBG I-VP O
DLBCL NNP B-NP O
confimed VBN B-VP O
by IN B-PP O
immunophenotyping VBG B-NP O
. . O O
Subsequent NNP B-NP O
bone NN I-NP O
marrow NN I-NP O
biopsy NN I-NP O
revealed VBD B-VP O
polyclonal JJ B-NP O
B-cell NN I-NP O
populations NNS I-NP O
and CC O O
an DT B-NP O
inverted JJ I-NP O
CD4/CD8 CC I-NP O
T NNP I-NP O
Cell NNP I-NP O
ratio NN I-NP O
, , O O
with IN B-PP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
monoclonal JJ B-NP O
proliferation NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
underwent IN B-PP O
his PRP$ B-NP O
initial JJ I-NP O
two CD I-NP O
cycles NNS I-NP O
of IN B-PP O
CHOP NNP B-NP O
in IN B-PP O
May NNP B-NP B-DATE
, , O O
and CC O O
experienced VBD B-VP O
no DT B-NP O
adverse JJ I-NP O
effects NNS I-NP O
except IN B-PP O
for IN B-PP O
generalized JJ B-NP O
weakness NN I-NP O
. . O O
PET NN B-NP O
exam NN I-NP O
in IN B-PP O
early JJ B-NP O
June NNP I-NP B-DATE
revealed VBD B-VP O
larger JJR B-NP O
left VBD B-VP O
groin NN B-NP O
mass NN I-NP O
, , O O
improvement NN B-NP O
in IN B-PP O
lymphadenopathy NN B-NP O
, , O O
and CC O O
a DT B-NP O
small JJ I-NP O
pancreatic JJ I-NP O
cystic JJ I-NP O
lesion NN I-NP O
. . O O
It PRP B-NP O
was VBD B-VP O
undetermined VBN I-VP O
whether IN B-PP O
this DT B-NP O
represented VBN I-NP O
treatment NN I-NP O
effect NN I-NP O
or CC O O
worsening VBG B-VP O
of IN B-PP O
disease NN B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
subsequently RB B-ADVP O
had VBD B-VP O
his PRP$ B-NP O
next JJ I-NP O
two CD I-NP O
CHOP NNP I-NP O
treatments NNS I-NP O
in IN B-PP O
mid JJ B-NP O
June NNP I-NP B-DATE
and CC O O
early JJ B-NP O
July NNP I-NP B-DATE
. . I-NP O
PET NNP I-NP O
scan NN I-NP O
and CC I-NP O
lymph NN I-NP O
node NN I-NP O
biopsy NN I-NP O
in IN B-PP O
early JJ B-NP O
July NNP I-NP B-DATE
revealed VBD B-VP O
unchanged JJ B-NP O
disease NN I-NP O
with IN B-PP O
evidence NN B-NP O
of IN B-PP O
fibrosis NN B-NP O
and CC I-NP O
inflammation NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN I-VP O
in IN B-PP O
clinic NN B-NP O
by IN B-PP O
Dr. NNP B-NP O
Quadri NNP I-NP B-DOCTOR
twice RB B-ADVP O
in IN B-PP O
July NNP B-NP B-DATE
, , O O
with IN B-PP O
the DT B-NP O
second JJ I-NP O
visit NN I-NP O
revealing VBG B-VP O
increased VBN B-NP O
PET NN I-NP O
avidity NN I-NP O
and CC I-NP O
persistence NN I-NP O
of IN B-PP O
the DT B-NP O
primary JJ I-NP O
mass NN I-NP O
. . O O
Given VBN B-VP O
the DT B-NP O
persistence NN I-NP O
of IN B-PP O
the DT B-NP O
mass NN I-NP O
and CC I-NP O
lack NN I-NP O
of IN B-PP O
response NN B-NP O
to TO B-PP O
CHOP NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Rodgers NNP I-NP B-DOCTOR
of IN B-PP O
the DT B-NP O
WDMC NNP I-NP B-HOSPITAL
one CD I-NP O
week NN I-NP O
later RB B-ADVP O
on IN B-PP O
7/28 CD B-NP B-DATE
for IN B-PP O
consideration NN B-NP O
of IN B-PP O
auto-SCT JJ B-NP O
vs NN I-NP O
more RBR B-NP O
aggressive JJ I-NP O
chemo NN I-NP O
regimen NNS I-NP O
. . O O
Due NNP O O
to TO B-PP O
the DT B-NP O
patient NN I-NP O
's POS B-NP O
age NN I-NP O
and CC I-NP O
consideration NN I-NP O
of IN B-PP O
risk/benefit NN B-NP O
, , O O
it PRP B-NP O
was VBD B-VP O
decided VBN I-VP O
that IN B-PP O
the DT B-NP O
best JJS I-NP O
approach NN I-NP O
would MD B-VP O
be VB I-VP O
to TO I-VP O
attempt VB I-VP O
a DT B-NP O
more RBR I-NP O
aggressive JJ I-NP O
chemo NN I-NP O
regimen VB B-VP O
first RB B-ADVP O
. . O O
Mr. NNP B-NP O
Nielson NNP I-NP B-PATIENT
was VBD B-VP O
admitted VBN I-VP O
on IN B-PP O
8/2/2097 CD B-NP B-DATE
to TO B-VP O
receive VB I-VP O
his PRP$ B-NP O
first JJ I-NP O
cycle NN I-NP O
of IN B-PP O
R-ICE NNP B-NP O
with IN B-PP O
dose-reduced JJ B-NP O
Ifos NNS I-NP O
and CC I-NP O
carboplatin NN I-NP O
becuase . O O
of IN B-PP O
h/o JJ B-NP O
nephrectomy NN I-NP O
. . O O
He PRP B-NP O
tolerated VBD B-VP O
the DT B-NP O
treatment NN I-NP O
fairly RB B-ADVP O
well RB I-ADVP O
with IN B-PP O
some DT B-NP O
panycytopenia NN I-NP O
. . O O
Patient NNP O O
felt VBD B-VP O
the DT B-NP O
R-ICE NNP I-NP O
regimen NNP I-NP O
was VBD B-VP O
a DT B-NP O
little JJ I-NP O
harder JJR I-NP O
on IN B-PP O
him PRP B-NP O
than IN B-PP O
the DT B-NP O
CHOP NNP I-NP O
regimen NNS I-NP O
. . O O
He PRP B-NP O
felt VBD B-VP O
effects NNS B-NP O
including VBG B-VP O
fatigue NN B-NP O
and CC I-NP O
constipation NN I-NP O
that IN B-PP O
resolved VBN B-NP O
back RB B-ADVP O
to TO B-PP O
baseline NN B-NP O
in IN B-PP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
. . O O
On IN B-PP O
8/9 CD B-NP B-DATE
, , O O
he PRP B-NP O
was VBD B-VP O
given VBN I-VP O
2 CD B-NP O
units NNS I-NP O
of IN B-PP O
packed VBN B-NP O
red JJ I-NP O
cells NNS I-NP O
due JJ B-ADJP O
to TO B-PP O
anemia NN B-NP O
and CC B-PP O
on IN B-PP O
8/16 CD B-NP B-DATE
, , O O
he PRP B-NP O
was VBD B-VP O
given VBN I-VP O
a DT B-NP O
unit NN I-NP O
of IN B-PP O
pheresis NN B-NP O
platelets NNS I-NP O
for IN B-PP O
his PRP$ B-NP O
thrombocytopenia NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
two CD B-NP O
units NNS I-NP O
of IN B-PP O
packed VBN B-NP O
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
for IN B-PP O
his PRP$ B-NP O
anemia NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
initially RB I-VP O
scheduled VBN I-VP O
to TO I-VP O
receive VB I-VP O
cycle NN B-NP O
2 CD I-NP O
of IN B-PP O
R-ICE NNP B-NP O
on IN B-PP O
8/22 CD B-NP B-DATE
but CC O O
that DT B-NP O
was VBD B-VP O
delayed VBN I-VP O
due JJ B-NP O
to TO B-PP O
his PRP$ B-NP O
thrombocytopenia NN I-NP O
. . O O
He PRP B-NP O
says VBZ B-VP O
that IN B-SBAR O
he PRP B-NP O
currently RB B-ADVP O
feels VBZ B-VP O
cold-intolerance NN B-NP O
and CC I-NP O
fatigue NN I-NP O
that WDT B-NP O
is VBZ B-VP O
the DT B-NP O
same JJ I-NP O
as IN B-PP O
when WRB B-ADVP O
he PRP B-NP O
first RB B-ADVP O
started VBD B-VP O
his PRP$ B-NP O
chemotherapy NN I-NP O
in IN B-PP O
May NNP B-NP B-DATE
. . O O
He PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
recent JJ I-NP O
N/V NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
constipation NN B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
orthostatic JJ B-NP O
dizziness NN I-NP O
, , O O
hematuria NN B-NP O
, , O O
BRBPR NNP B-NP O
, , O O
or CC O O
melena NN B-NP O
. . O O
Side NNP B-NP O
effects NNS I-NP O
of IN B-PP O
note NN B-NP O
from IN B-PP O
previous JJ B-NP O
cycles NNS I-NP O
of IN B-PP O
chemotherapy NN B-NP O
include VBP B-VP O
generalized JJ B-NP O
weakness NN I-NP O
, , O O
cold-intolerance NN B-NP O
, , O O
and CC O O
constipation NN B-NP O
. . O O
PMH: . O O
1 LS O O
. . O O
Wegener NNP B-NP O
's POS B-NP O
Granulomatosis NNP I-NP O
- : O O
treated VBN B-VP O
successfully RB B-ADVP O
and CC O O
maintained VBD B-VP O
on IN B-PP O
low JJ B-NP O
dose NN I-NP O
steroids NNS I-NP O
2. `` B-NP O
DM NNP I-NP O
II NNP I-NP O
3. . B-NP O
CAD NN I-NP O
4 CD B-LST O
. . O O
Known VBN B-VP O
Aortic NNP B-NP O
Stenosis NNP I-NP O
w/ VBD B-VP O
valve JJ B-NP O
area NN I-NP O
1.3 CD O O
PSH NNS B-NP O
1 LS O O
. . O O
s/p VB B-VP O
L NNP B-NP O
nephrectomy NN I-NP O
in IN B-PP O
60 CD B-NP I-DATE
's POS B-LST I-DATE
2. DT B-NP O
b/l NN I-NP O
Knee NNP I-NP O
repairs NNS I-NP O
3. DT B-NP O
s/p NN I-NP O
R NN I-NP O
hip NN I-NP O
repair NN I-NP O
Allergies/Adverse NNP B-NP O
Reactions NNS I-NP O
1 CD B-NP O
. . O O
NKDA NNP O O
Medications NNS B-NP O
: : O O
glyburide NN B-NP O
10 CD I-NP O
mg/d NN I-NP O
atorvastatin IN B-PP O
10 CD B-NP O
mg/d NN I-NP O
furosemide NN B-NP O
40 CD I-NP O
mg/d NN I-NP O
MVI . O O
Prednisone NN B-NP O
5 CD I-NP O
mg/d NN I-NP O
Bactrim NNP B-NP O
DS NNPS I-NP O
M,W, NNP I-NP O
F NNP I-NP O
SH NNS B-NP O
: : O O
Lives NNS B-NP O
with IN B-PP O
wife NN B-NP O
in IN B-PP O
Port NNP B-NP B-CITY
Arthur NNP I-NP I-CITY
, , O O
IN IN B-PP B-STATE
. . B-NP O
She PRP B-NP O
is VBZ B-VP O
currently RB B-ADVP O
in IN B-PP O
Internal NNP B-NP O
Medicine NNP I-NP O
20 CD I-NP O
due JJ B-ADJP O
to TO B-PP O
mobility NN B-NP O
problems NNS I-NP O
. . O O
Cites NNS B-NP O
family NN I-NP O
as IN B-PP O
major JJ B-NP O
source NN I-NP O
of IN B-PP O
support NN B-NP O
with IN B-PP O
daughter NN B-NP O
taking VBG B-VP O
care NN B-NP O
of IN B-PP O
organizing VBG B-VP O
his PRP$ B-NP O
medications NNS I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
formerly RB B-ADVP O
a DT B-NP O
security NN I-NP B-PROFESSION
officer NN I-NP I-PROFESSION
for IN B-PP O
a DT B-NP O
technology NN I-NP B-ORGANIZATION
company NN I-NP I-ORGANIZATION
and CC O O
denies VBZ B-VP O
any DT B-NP O
exposures NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
a DT B-NP O
40 CD I-NP O
pk NN I-NP O
year NN I-NP O
smoking NN I-NP O
history NN I-NP O
; : O O
non-smoking JJ B-ADVP O
for IN B-PP O
25 CD B-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
a DT B-NP O
heavy JJ I-NP O
ETOH NNP I-NP O
history NN I-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
that IN B-SBAR O
he PRP B-NP O
reduced VBD B-VP O
to TO B-PP O
a DT B-NP O
beer NN I-NP O
or CC I-NP O
martini NN I-NP O
every DT B-NP O
day NN I-NP O
in IN B-PP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
years NNS I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
resistant JJ B-ADJP O
to TO B-PP O
giving VBG B-VP O
further JJ B-NP O
details NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
not RB I-VP O
had VBN I-VP O
anything NN B-NP O
to TO B-VP O
drink VB I-VP O
since IN B-SBAR O
he PRP B-NP O
started VBD B-VP O
his PRP$ B-NP O
chemotherapy NN I-NP O
regiment NN I-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
history NN B-NP O
of IN B-PP O
illicit JJ B-NP O
drugs NNS I-NP O
, , O O
IV NNP B-NP O
abuse NN I-NP O
, , O O
or CC O O
h/o RB B-NP O
STDs NNS I-NP O
and CC O O
is VBZ B-VP O
not RB O O
currently RB B-ADVP O
sexually RB B-ADJP O
active JJ I-ADJP O
. . O O
FH NNP B-NP O
: : O O
- : B-VP O
Father NN B-NP O
: : O O
Colon NNP B-NP O
carcinoma NN I-NP O
, , O O
Mother NNP B-NP O
: : O O
Breast NN B-NP O
cancer NN I-NP O
, , O O
Brother NNP B-NP O
: : O O
unknown JJ B-NP O
cancer NN I-NP O
. . O O
No DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
CAD. . O O
ROS NNP B-NP O
: : O O
Please VB B-VP O
see VB I-VP O
pertinent JJ B-NP O
positives NNS I-NP O
and CC I-NP O
negatives NNS I-NP O
in IN B-PP O
HPI. NNP B-NP O
Otherwise RB I-NP O
negative JJ I-NP O
in IN B-PP O
detail NN B-NP O
. . O O
Physical JJ B-NP O
Exam NNP I-NP O
: : O O
V NNP B-NP O
: : O O
P NNP B-NP O
: : O O
78 CD B-NP O
, , O O
regular JJ B-NP O
BP NNP I-NP O
: : O O
104/60 CD B-NP O
RR NN I-NP O
: : O O
20 CD B-NP O
T NNP I-NP O
: : O O
96.5 CD B-NP O
O2 NNP I-NP O
sat VBD B-VP O
: : O O
98 CD B-NP O
on IN B-PP O
RA NNP B-NP O
WT NNP I-NP O
: : O O
255 CD B-NP O
lbs NNS I-NP O
Height NN I-NP O
: : O O
66.5 CD B-NP O
inches NNS I-NP O
Gen NNP B-NP O
: : O O
obese NN B-NP O
, , I-NP O
good-natured JJ I-NP O
, , O O
well RB B-ADVP O
appearing VBG B-VP O
, , O O
well RB B-ADVP O
nourished JJ B-NP O
, , I-NP O
pleasant JJ I-NP O
and CC I-NP O
appropriate JJ I-NP O
in IN B-PP O
NAD NNP B-NP O
HEENT NNP B-NP O
: : O O
normocephalic JJ B-NP O
, , I-NP O
atraumatic JJ I-NP O
, , I-NP O
sclerae NNS I-NP O
anicteric JJ I-NP O
, , I-NP O
conjunctiva JJ I-NP O
pink JJ I-NP O
, , I-NP O
OP NNP I-NP O
clear JJ I-NP O
( -LRB- I-NP O
dentition NN I-NP O
present NN I-NP O
) -RRB- I-NP O
with IN B-PP O
no DT B-NP O
frank JJ I-NP O
lesions NNS I-NP O
, , O O
moist JJ B-NP O
mucous JJ I-NP O
membranes NNS I-NP O
Neck NNP B-NP O
: : O O
supple NN B-NP O
, , O O
JVP NNP B-NP O
not RB I-NP O
able JJ B-ADJP O
to TO B-VP O
be VB I-VP O
appreciated VBN I-VP O
due JJ B-NP O
to TO B-PP O
large JJ B-NP O
body NN I-NP O
habitus NN I-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
noted VBD B-VP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
, , O O
no DT B-NP O
cervical/clavicular JJ I-NP O
LAD NN I-NP O
Cor NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
nlS1S2 NN B-NP O
, , O O
loud JJ B-ADJP O
2/6 IN B-PP O
crescendo-decrescendo NN B-NP O
murmur NN I-NP O
heard VBD B-VP O
best JJS B-ADVP O
at IN B-PP O
LUSB NNP B-NP O
radiating NN I-NP O
to TO B-PP O
clavical JJ B-NP O
. . I-NP O
Radial NNP I-NP O
pulses VBZ B-VP O
2+ JJ B-NP O
b/l NN I-NP O
. . O O
Lungs NNP B-NP O
: : O O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
bilaterally RB B-ADVP O
, , O O
no DT B-NP O
crackles NNS I-NP O
, , O O
no DT B-NP O
wheezes NNS I-NP O
, , O O
I/E . O O
Abd NNP B-NP O
: : O O
Large JJ B-NP O
, , O O
ND NNP B-NP O
per IN B-PP O
Pt NNP B-NP O
report NN I-NP O
, , O O
+BS NNP B-NP O
, , O O
soft/NT. NN B-NP O
No DT I-NP O
splenomegaly JJ I-NP O
or CC O O
hepatomegaly RB B-ADJP O
appreciated VBN I-ADJP O
. . O O
Rectal NNP B-NP O
: : O O
deferred VBN B-VP O
by IN B-PP O
examiner NN B-NP O
Nodes NNP B-NP O
: : O O
No DT B-NP O
lymphadenopathy NN I-NP O
appreciated VBD B-VP O
, , O O
negative JJ B-ADJP O
in IN B-PP O
detail NN B-NP O
in IN B-PP O
left JJ B-NP O
and CC I-NP O
right JJ I-NP O
groin NN I-NP O
Extr NNP B-NP O
: : O O
right JJ B-NP O
ankle NN I-NP O
edema NN I-NP O
, , O O
2+ JJ B-NP O
DP/PT/rad NNP I-NP O
pulses NNS I-NP O
Neuro NNP B-NP O
: : O O
A+O NNP B-NP O
to TO B-PP O
person/place/time NN B-NP O
, , O O
CN NNP B-NP O
II NNP I-NP O
through IN B-PP O
XII NNP B-NP O
intact JJ I-NP O
( -LRB- I-NP O
CN NNP I-NP O
VIII NNP I-NP O
: : O O
diminished JJ B-NP O
hearing NN I-NP O
bilaterally RB B-VP O
) -RRB- I-VP O
, , O O
motor NN B-NP O
5/5 IN B-PP O
UE NNP B-NP O
and CC O O
LE JJ B-NP O
b/l NN I-NP O
, , O O
sensory JJ B-NP O
intact JJ I-NP O
, , I-NP O
DTRs JJ I-NP O
1+ JJ I-NP O
and CC I-NP O
symmetric JJ I-NP O
, , O O
finger NN B-NP O
to TO B-PP O
nose NN B-NP O
nl RB I-NP O
, , O O
gait NN B-NP O
nl NN I-NP O
, , O O
Rhomberg NNP B-NP O
neg NN I-NP O
Skin NNP B-NP O
: : O O
no DT B-NP O
rashes/sores NNS I-NP O
, , O O
good JJ B-NP O
skin NN I-NP O
turgor NN I-NP O
. . O O
Multiple VB B-VP O
ecchymoses VBZ I-VP O
present VB I-VP O
on IN B-PP O
arms NNS B-NP O
attributed VBN B-VP O
by IN B-PP O
Pt JJ B-NP O
to TO B-PP O
"bumping VBG B-VP O
into IN B-PP O
things NNS B-NP O
" '' O O
and CC O O
Ivs NNPS O O
Labs NNS B-NP O
and CC I-NP O
Studies NNS I-NP O
: : O O
Chemistries NNP B-NP O
: : O O
MAH NNP B-NP B-HOSPITAL
YC NNP I-NP O
LAB NNP I-NP O
28-Aug-2097 . O B-DATE
09:08 CD O O
Accession NNP B-NP O
# # I-NP O
6969S47715 CD O B-MEDICALRECORD
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Plasma NNP B-NP O
Sodium NNP I-NP O
143 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
3.9 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
108 CD I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
24.8 CD I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Calcium NNP B-NP O
9.0 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
21 CD I-NP O
(8-25 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
1.5 CD I-NP O
( -LRB- I-NP O
0.6-1.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Plasma NNP B-NP O
Glucose NN I-NP O
101 CD B-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Protein NNP I-NP O
6.4 CD I-NP O
( -LRB- I-NP O
6.0-8.3 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Albumin NNP B-NP O
3.7 CD I-NP O
( -LRB- O O
3.3-5.0) CD B-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
2.7 CD I-NP O
( -LRB- I-NP O
2.6-4.1 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.7 CD I-NP O
( -LRB- O O
0.0-1.0) CD B-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
56 CD I-NP O
( -LRB- I-NP O
45-115 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGPT NN B-NP O
21 CD I-NP O
( -LRB- B-NP O
10-55 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGOT JJ B-NP O
30 CD I-NP O
( -LRB- I-NP O
10-40 CD I-NP O
) -RRB- I-NP O
U/L . O O
Lactic NNP B-NP O
Dehydrogenase NNP I-NP O
379 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
110-210 CD I-NP O
) -RRB- I-NP O
U/L . O O
Blood NN B-NP O
Counts NNS I-NP O
: : O O
MAH NNP B-NP B-HOSPITAL
YC NNP I-NP O
LAB NNP I-NP O
28-Aug-2097 . O B-DATE
09:08 CD O O
Accession NNP B-NP O
# # I-NP O
6969S47715 CD O B-MEDICALRECORD
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
WBC NNP B-NP O
7.2 CD I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
31.6 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
HGB RB B-NP O
10.6 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
13.5-17.5 CD I-NP O
) -RRB- I-NP O
gm/dl . O O
RBC NNP B-NP O
3.64 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
4.50-5.90 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NN B-NP O
103 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
150-350 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
87 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
29.0 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
33.4 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
20.1 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
DIFFERENTIAL NNP B-NP O
REQUEST NNP I-NP O
RECEIVED NNP I-NP O
Diff JJ B-NP O
Method NNP I-NP O
Auto NN I-NP O
Poly NNP B-NP O
81 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
11 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NN B-NP O
7 CD I-NP O
( -LRB- I-NP O
4-11 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
(0-8 CD I-NP O
) -RRB- O O
% NN O O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
5.82 CD I-NP O
( -LRB- I-NP O
1.8-7.7 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
0.84 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
1.0-4.8 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.48 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.2-0.4 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.09 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
0.1-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.01 CD I-NP O
( -LRB- I-NP O
0.0-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Aniso NNP B-NP O
2+ FW I-NP O
( -LRB- I-NP O
NORMAL NN I-NP O
) -RRB- O O
Hypo NNP B-NP O
1+ FW I-NP O
( -LRB- I-NP O
NORMAL NN I-NP O
) -RRB- O O
Macrocytes NNP B-NP O
None NN I-NP O
Microcytes NNS B-NP O
None NN I-NP O
? . B-NP O
Radiology NNP I-NP O
: : O O
Report NNP B-NP O
from IN B-PP O
last JJ B-NP O
PET NNP I-NP O
CT NNP I-NP O
study NN I-NP O
7/18 VBD B-VP B-DATE
: : O O
IMPRESSION NN B-NP O
: : O O
Please VB B-VP O
see VB I-VP O
reports NNS B-NP O
of IN B-PP O
concurrent JJ B-NP O
CT JJ I-NP O
neck NN I-NP O
and CC O O
chest NN B-NP O
and CC I-NP O
PET NN I-NP O
examination NN B-NP O
for IN B-PP O
anatomic JJ B-NP O
and CC I-NP O
physiologic JJ I-NP O
evaluation NN I-NP O
of IN B-PP O
those DT O O
regions NNS B-NP O
. . O O
1 CD B-NP O
. . O O
No DT B-NP O
significant JJ I-NP O
change NN I-NP O
in IN B-PP O
left JJ B-NP O
external JJ I-NP O
iliac NN I-NP O
and CC O O
left VBD B-VP O
inguinal JJ O O
hypermetabolic JJ B-NP O
lymphadenopathy NN I-NP O
. . O O
2. PRP B-NP O
Likely RB B-ADVP O
right RB B-ADVP O
greater JJR B-NP O
trochanteric NN I-NP O
bursitis NN I-NP O
. . O O
3. CD B-NP O
Status NNP I-NP O
post NN I-NP O
left VBD B-VP O
nephrectomy NN B-NP O
and CC I-NP O
cholecystectomy NN I-NP O
. . O O
4 CD B-LST O
. . O O
Small NNP B-NP O
pancreatic JJ I-NP O
cystic JJ I-NP O
lesion NN I-NP O
seen VBN B-VP O
on IN B-PP O
prior JJ B-NP O
PET NN I-NP O
CT NN I-NP O
is VBZ B-VP O
not RB O O
seen VBN B-PP O
on IN B-PP O
current JJ B-NP O
study NN I-NP O
likely JJ B-NP O
secondary JJ I-NP O
to TO I-NP O
slice VB I-NP O
selection NN I-NP O
. . O O
For IN B-PP O
further JJR B-NP O
results NNS I-NP O
please VB B-VP O
consult VB I-VP O
CAS. . O O
? . B-NP O
Echocardiogram NNP I-NP O
: : O O
4/22/97 CD O B-DATE
Aortic NNP B-NP O
valve NN I-NP O
area NN I-NP O
= SYM O O
1.3 CD B-NP O
cm^2 CD I-NP O
, , O O
EF=74 NNP B-NP O
% NN I-NP O
, , O O
evidence NN B-NP O
of IN B-PP O
small JJ B-NP O
pericardial JJ I-NP O
effusion NN I-NP O
( -LRB- B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
tamponade NN B-NP O
) -RRB- I-NP O
, , O O
mild JJ B-NP O
mitral JJ I-NP O
regurg NN I-NP O
, , O O
mild JJ B-NP O
pulmonary JJ I-NP O
insufficiency NN I-NP O
. . O O
No DT B-NP O
evidence NN I-NP O
of IN B-PP O
aortic JJ B-NP O
insufficiency NN I-NP O
. . O O
Assessment NNP B-NP O
and CC I-NP O
Plan NNP I-NP O
: : O O
Mr. NNP B-NP O
Nielson NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
77 CD I-NP B-AGE
yoM NNP I-NP O
w/ NN I-NP O
Stage NNP I-NP O
IIIB NNP I-NP O
diffuse VBP B-VP O
large JJ B-NP O
B-cell JJ I-NP O
lymphoma NN I-NP O
s/p NN I-NP O
4 CD B-NP O
cycles NNS I-NP O
of IN B-PP O
CHOP NNP B-NP O
and CC O O
1 CD B-NP O
cycle NN I-NP O
of IN B-PP O
R-ICE NNP B-NP O
who WP B-NP O
presents VBZ B-VP O
now RB B-ADVP O
for IN B-PP O
cycle NN B-NP O
2 CD I-NP O
of IN B-PP O
R-ICE. NNP B-NP O
PMH NNP I-NP O
is VBZ B-VP O
significant JJ B-ADJP O
for IN B-PP O
aortic JJ B-NP O
stenosis NN I-NP O
( -LRB- I-NP O
EF NNP I-NP O
74 CD I-NP O
% NN I-NP O
, , I-NP O
valve JJ I-NP O
area NN I-NP O
: : O O
1.3 CD B-NP O
) -RRB- I-NP O
, , O O
steroid JJ B-NP O
induced JJ I-NP O
DMII NNP I-NP O
, , O O
and CC O O
Wegener NNP B-NP O
's POS B-NP O
. . O O
1 CD B-NP O
) -RRB- I-NP O
R-ICE NN I-NP O
, , O O
starting VBG B-VP O
today NN B-NP O
a DT B-NP O
) -RRB- I-NP O
Monitor NNP I-NP O
CBCs NNP I-NP O
, , O O
lytes(also RB B-ADVP O
Mg NNP B-NP O
, , O O
Phosphorus NNP B-NP O
, , O O
Calcium NNP B-NP O
, , O O
uric JJ B-NP O
acid NN I-NP O
) -RRB- I-NP O
, , O O
LDH NNP B-NP O
b NN B-NP O
) -RRB- I-NP O
Monitor NN I-NP O
renal JJ I-NP O
toxicity( NN I-NP O
only RB B-NP O
one CD I-NP O
kidney NN I-NP O
) -RRB- I-NP O
with IN B-PP O
daily JJ B-NP O
U/A NNP I-NP O
and CC I-NP O
Cr NNP I-NP O
, , O O
BUN NNP B-NP O
c NNS B-NP O
) -RRB- I-NP O
Aggressive NNP I-NP O
hydration NN I-NP O
, , O O
concurrent JJ B-NP O
Mesna NNP I-NP O
d NN B-NP O
) -RRB- I-NP O
Receive VBP B-VP O
200 CD B-NP O
mcg JJ I-NP O
dosage NN I-NP O
of IN B-PP O
Aranesp NNP B-NP O
today NN I-NP O
, , O O
Neulasta NNP B-NP O
on IN B-LST O
D5 CD B-SBAR O
2) JJ B-NP O
Wegener NNP I-NP O
's POS B-LST O
a DT B-NP O
) -RRB- I-NP O
Holding NNP I-NP O
home NN I-NP O
prednisone NN I-NP O
while IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
getting VBG I-VP O
dexamthasone NN B-NP O
as IN B-PP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
R-ICE NNP I-NP O
protocol NN I-NP O
b NN B-NP O
) -RRB- I-NP O
Restart NN I-NP O
on IN B-PP O
D/C NNP B-NP O
3)DMI NN B-NP O
I PRP O O
a DT B-NP O
) -RRB- I-NP O
Maintaining NNP I-NP O
on IN B-PP O
home NN B-NP O
regiment NN I-NP O
of IN B-PP O
glyburide NN B-NP O
10 CD I-NP O
mg NN I-NP O
po NN I-NP O
qam NN I-NP O
with IN B-PP O
BID NNP B-NP O
fingersticks NNS I-NP O
b NN B-NP O
) -RRB- I-NP O
Switch NN I-NP O
to TO B-VP O
RISS VB I-VP O
if IN B-SBAR O
necessary JJ O O
4)Aortic JJ B-NP O
stenosis NN I-NP O
a DT B-NP O
) -RRB- I-NP O
Continue NNP I-NP O
lasix NN I-NP O
5)Ppx JJ B-NP O
: : O O
ranitidine NN B-NP O
, , O O
ambulating NN B-NP O
6)Dispo NN B-NP O
: : O O
Upon IN B-PP O
completion NN B-NP O
of IN B-PP O
infusions NNS B-NP O
and CC O O
when WRB B-ADVP O
clinically RB B-NP O
stable JJ I-NP O
, , O O
approximately RB B-ADVP O
4 CD B-NP O
days NNS I-NP O
Rian NNP B-NP B-DOCTOR
Vicente NNP I-NP I-DOCTOR
Internal NNP I-NP O
Medicine NNP I-NP O
Pager NNP B-NP O
34166 CD I-NP B-PHONE
Tuburculosis NNP B-NP B-HOSPITAL
Hospital NN I-NP I-HOSPITAL
Team NNP B-NP O
III NNP I-NP O
Intern NNP I-NP O
Addendum NN I-NP O
I PRP B-NP O
have VBP B-VP O
seen VBN I-VP O
and CC O O
examined VBN B-VP O
the DT B-NP O
pt NN I-NP O
and CC O O
I PRP B-NP O
agree VBP B-VP O
with IN B-PP O
excellent JJ B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
note NN I-NP O
above IN B-PP O
. . O O
In IN B-PP O
brief JJ B-NP O
, , O O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
77 CD I-NP B-AGE
yo NNP I-NP O
man NN I-NP O
w/ VBD B-VP O
Stage NNP B-NP O
IIIB NNP I-NP O
diffuse VBP B-VP O
large JJ B-NP O
B-cell JJ I-NP O
lymphoma NN I-NP O
s/p NN I-NP O
4 CD B-NP O
cycles NNS I-NP O
of IN B-PP O
CHOP NNP B-NP O
and CC O O
1 CD B-NP O
cycle NN I-NP O
of IN B-PP O
R-ICE NNP B-NP O
her PRP B-NP O
now RB B-ADVP O
for IN B-PP O
his PRP$ B-NP O
cycle NN I-NP O
2 CD B-NP O
of IN B-PP O
R-ICE. NNP B-NP O
We PRP B-NP O
will MD B-VP O
maintain VB I-VP O
hydration NN B-NP O
and CC I-NP O
monitor NN I-NP O
renal JJ I-NP O
function NN I-NP O
as IN B-PP O
this DT B-NP O
pt NN I-NP O
has VBZ B-VP O
only RB B-NP O
one CD I-NP O
kidney NN I-NP O
. . O O
His PRP$ B-NP O
type NN I-NP O
two CD B-NP O
diabetes NNS I-NP O
will MD B-VP O
be VB I-VP O
controlled VBN I-VP O
with IN B-PP O
his PRP$ B-NP O
home NN I-NP O
regimen NNS I-NP O
and CC O O
his PRP$ B-NP O
maintenance NN I-NP O
steroids NNS I-NP O
that IN B-SBAR O
he PRP B-NP O
takes VBZ B-VP O
for IN B-SBAR O
Wegener NNP B-NP O
's POS B-NP O
will MD B-VP O
be VB I-VP O
held VBN I-VP O
as IN B-SBAR O
they PRP B-NP O
are VBP B-VP O
replaced VBN I-VP O
by IN B-PP O
dexamethasone NN B-NP O
via IN B-PP O
R-ICE. NNP B-NP O
We PRP B-NP O
will MD B-VP O
transfuse VB I-VP O
to TO I-VP O
maintain VB I-VP O
platelets NNS B-NP O
over IN B-PP O
20K JJ B-NP O
and CC I-NP O
HCT NNP I-NP O
over IN B-PP O
25 CD B-NP O
as IN B-PP O
needed VBN B-NP O
. . O O
His PRP$ B-NP O
exam NN I-NP O
is VBZ B-VP O
non-concerning JJ B-ADJP O
. . O O
Nicolas NNP B-NP B-DOCTOR
Etheridge NNP I-NP I-DOCTOR
MD NNP I-NP O
, , O O
PhD NNP B-NP O
Pager NNP B-NP O
5-8560 CD I-NP B-PHONE
PGY-1 NN B-NP O
